siRNA treatment reduces triglycerides in individuals with uncommon problem

.INVESTIGATION HIGHLIGHT.19 September 2024.

Plozasiran decreased triglyceride degrees through 80% and also decreased the danger of pancreatitis in individuals along with relentless chylomicronemia, with or without a hereditary medical diagnosis.